Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Wai Yuen Tong Medicine Holdings Limited ( (HK:0897) ) just unveiled an update.
Wai Yuen Tong Medicine Holdings Limited announced that all resolutions proposed at its Annual General Meeting held on 19 August 2025 were passed unanimously by shareholders. This includes the re-election of directors, re-appointment of auditors, and approval of amendments to the share option scheme, indicating strong shareholder support and stability in the company’s governance and strategic direction.
The most recent analyst rating on (HK:0897) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Wai Yuen Tong Medicine Holdings Limited stock, see the HK:0897 Stock Forecast page.
More about Wai Yuen Tong Medicine Holdings Limited
Wai Yuen Tong Medicine Holdings Limited is a company incorporated in Bermuda with limited liability, primarily operating in the pharmaceutical industry. The company focuses on producing and distributing traditional Chinese medicine products.
Average Trading Volume: 548,681
Technical Sentiment Signal: Buy
Current Market Cap: HK$365.7M
Find detailed analytics on 0897 stock on TipRanks’ Stock Analysis page.